Acessibilidade / Reportar erro
Guidelines Questions • Rev. Assoc. Med. Bras. 66 (12) • Dec 2020 • https://doi.org/10.1590/1806-9282.66.12.1620   copy

Amyloidosis: the use of the Daratumumab

Authorship SCIMAGO INSTITUTIONS RANKINGS

QUESTION: What is the role of daratumumab in the treatment of Amyloidosis?

ANSWER: The use of daratumumab in patients with clinical symptoms of amyloidosis currently should not be recommended due to the weakness of the evidence available to support it. 11. Anzai, Adriano et. al. Use of daratumumab in patients with amyloidosis. Rev Assoc Med Bras 2020; 66(11):1468-1471.

REFERENCES

  • 1
    Anzai, Adriano et. al. Use of daratumumab in patients with amyloidosis. Rev Assoc Med Bras 2020; 66(11):1468-1471.

Publication Dates

  • Publication in this collection
    16 Dec 2020
  • Date of issue
    Dec 2020
Creative Common - by-nc 4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Associação Médica Brasileira R. São Carlos do Pinhal, 324, 01333-903 São Paulo SP - Brazil, Tel: +55 11 3178-6800, Fax: +55 11 3178-6816 - São Paulo - SP - Brazil
E-mail: ramb@amb.org.br
Acompanhe os números deste periódico no seu leitor de RSS